<?xml version="1.0" encoding="UTF-8"?>
<p>In the last few years, different sciIAVs have been described and used in multiple in vitro and in vivo applications, such as the study of segment incorporation and packaging signals [
 <xref rid="B194-viruses-11-00190" ref-type="bibr">194</xref>,
 <xref rid="B195-viruses-11-00190" ref-type="bibr">195</xref>], neutralization assays [
 <xref rid="B196-viruses-11-00190" ref-type="bibr">196</xref>], screening of neutralizing antibodies [
 <xref rid="B106-viruses-11-00190" ref-type="bibr">106</xref>] or antivirals [
 <xref rid="B197-viruses-11-00190" ref-type="bibr">197</xref>], drug resistance [
 <xref rid="B198-viruses-11-00190" ref-type="bibr">198</xref>,
 <xref rid="B199-viruses-11-00190" ref-type="bibr">199</xref>], HA complementation [
 <xref rid="B102-viruses-11-00190" ref-type="bibr">102</xref>], NA functional analysis [
 <xref rid="B200-viruses-11-00190" ref-type="bibr">200</xref>], or the development of vaccines [
 <xref rid="B107-viruses-11-00190" ref-type="bibr">107</xref>,
 <xref rid="B201-viruses-11-00190" ref-type="bibr">201</xref>,
 <xref rid="B202-viruses-11-00190" ref-type="bibr">202</xref>,
 <xref rid="B203-viruses-11-00190" ref-type="bibr">203</xref>,
 <xref rid="B204-viruses-11-00190" ref-type="bibr">204</xref>,
 <xref rid="B205-viruses-11-00190" ref-type="bibr">205</xref>,
 <xref rid="B206-viruses-11-00190" ref-type="bibr">206</xref>,
 <xref rid="B207-viruses-11-00190" ref-type="bibr">207</xref>,
 <xref rid="B208-viruses-11-00190" ref-type="bibr">208</xref>,
 <xref rid="B209-viruses-11-00190" ref-type="bibr">209</xref>,
 <xref rid="B210-viruses-11-00190" ref-type="bibr">210</xref>,
 <xref rid="B211-viruses-11-00190" ref-type="bibr">211</xref>,
 <xref rid="B212-viruses-11-00190" ref-type="bibr">212</xref>,
 <xref rid="B213-viruses-11-00190" ref-type="bibr">213</xref>,
 <xref rid="B214-viruses-11-00190" ref-type="bibr">214</xref>]. The main advantage of using sciIAVs as LAIVs is that host immune response may be elicited without causing the pathogenesis that is associated with viral replication and progeny production [
 <xref rid="B107-viruses-11-00190" ref-type="bibr">107</xref>,
 <xref rid="B205-viruses-11-00190" ref-type="bibr">205</xref>]. In this case, it is important to consider the impact of the missing gene in immunogenicity, because some of the sciIAVs that are deficient in polymerase (PB2, PB1 or PA) segments may have limited levels of viral replication and gene transcription, thus compromising the induction of B or T cell immune responses and protection efficacy.
</p>
